ReviewToxicology research2025
Next- Gen Detox: Nanoparticles strategies for liver and kidney toxin removal.
Review in Toxicology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The liver and kidneys are central to maintaining systemic homeostasis by removing endogenous and exogenous toxins. However, toxin accumulation can compromise these organs' detoxification capacity, leading to functional impairment and disease progression. Recent advances in nanotechnology have opened new avenues for enhancing detoxification strategies, particularly through the application of functionalized nanoparticles (NPs). Engineered NPs can selectively bind, sequester, or neutralize harmful compounds, while nano-adsorbents have shown promise in improving the efficiency of renal replacement therapies such as dialysis. Moreover, targeted nanocarriers enable site-specific drug delivery, minimizing off-target effects and enhancing therapeutic efficacy. This review explores the mechanistic interactions of NPs within hepatic and renal detoxification pathways, emphasizing their potential in managing hepatotoxicity and enhancing renal filtration. Highlighted case studies underscore the translational promise of NP-based interventions. Nevertheless, key challenges remain, including NP-induced immunogenicity, cytotoxicity, bioaccumulation, and regulatory hurdles. Future research should prioritize the optimization of NP biocompatibility, refinement of targeted delivery systems, and long-term safety evaluations. A deeper understanding of the nano-bio interface is crucial for unlocking the full potential of nanotechnology in detoxification therapeutics. Addressing these challenges could usher in a new era of precision medicine for liver and kidney health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.